Orchestra BioMed Holdings Income Statement (2020-2026) | OBIO

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.87M0.40M1.16M1.10M1.16M0.92M0.42M0.26M0.62M0.78M0.99M0.25M0.87M0.84M0.86M30.92M0.11M
Gross Profit (Quarter)
0.82M0.34M1.11M1.05M1.12M0.86M0.38M0.21M0.59M0.73M0.92M0.20M0.82M0.79M0.81M30.87M0.08M
Operating items
Depreciation & Amortization - Total (Quarter)
0.07M0.07M0.08M0.08M0.08M0.08M0.08M
Research & Development (Quarter)
3.47M5.03M5.90M7.54M8.25M8.50M8.56M8.51M9.11M11.13M11.60M10.97M13.48M13.85M14.03M16.82M15.78M
Wages, Salaries and Other (Quarter)
5.49M5.91M6.03M5.17M6.66M7.00M6.82M9.54M8.79M
Selling, General & Administrative (Quarter)
0.07M0.06M0.06M2.48M2.95M5.28M3.33M4.41M5.32M6.34M4.18M5.90M6.47M5.67M5.90M6.26M6.26M7.10M7.29M6.37M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
-0.60M-0.21M-0.21M0.08M0.60M0.91M1.21M-0.34M0.96M0.88M0.92M0.52M0.17M-0.04M-0.52M-0.51M1.39M
Operating Expenses (Quarter)
0.07M0.06M0.06M5.99M8.04M11.23M10.93M12.71M13.87M14.94M12.74M15.04M17.64M17.33M16.93M19.79M20.16M21.17M24.16M22.19M
Operating Income (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M6.75M-22.08M
EBIT (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M6.75M-22.08M
Non-operating items
Non Operating Investment Income (Quarter)
0.00M0.00M0.00M-0.22M1.73M-0.31M-0.17M-0.03M-0.06M0.02M-0.29M0.00M-0.01M0.12M-0.05M-0.01M-0.02M0.03M0.01M-0.10M
Interest & Investment Income (Quarter)
0.92M1.11M1.02M0.90M0.92M0.52M0.17M-0.04M-0.52M-0.76M-0.82M
Other Non Operating Income (Quarter)
0.68M-0.01M-0.04M
Non Operating Income (Quarter)
-0.01M
Net income details
EBT (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-22.90M
Profit After Tax (Quarter)
-0.09M-0.09M-0.09M-5.73M-7.85M-10.28M-9.75M-10.94M-12.05M-13.32M-12.82M-13.46M-15.98M-15.43M-16.16M-18.75M-19.36M-20.83M6.25M-20.69M
Income from Non-Controlling Interests (Quarter)
-0.09M
Income from Continuing Operations (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-22.90M
Consolidated Net Income (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-22.90M
Income towards Parent Company (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-22.90M
Preferred Dividend Payments (Quarter)
-0.04M
Net Income towards Common Stockholders (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-20.66M
Additional items
EPS (Basic) (Quarter)
0.000.00-0.01-0.62-0.77-0.51-0.44-0.40-0.35-0.38-0.37-0.38-0.45-0.41-0.43-0.49-0.50-0.400.26-0.33
EPS (Weighted Average and Diluted) (Quarter)
0.000.00-0.01-0.56-0.77-0.51-0.44-0.40-0.35-0.38-0.37-0.38-0.45-0.41-0.43-0.49-0.50-0.400.26-0.33
Shares Outstanding (Weighted Average) (Quarter)
20.45M20.45M1.19M9.23M1.33M1.33M2.93M1.97M32.59M33.23M1.95M35.79M37.62M2.00M0.75M2.06M9.31M9.28M62.72M
Shares Outstanding (Diluted Average) (Quarter)
20.45M20.45M20.45M9.23M18.45M20.19M14.99M27.64M31.23M35.24M33.23M35.78M35.79M37.62M36.82M38.24M38.31M52.19M47.75M62.72M
EBITDA (Quarter)
-0.10M-0.09M-0.09M-5.73M-7.85M-10.28M-9.76M-10.97M-12.11M-13.30M-12.75M-13.46M-15.99M-15.30M-16.20M-18.77M-19.38M-20.80M6.26M-20.79M
Shares Outstanding (Quarter)
4.45M4.45M2.19M10.14M20.19M20.19M35.69M31.74M35.74M35.74M35.78M35.78M35.82M37.94M38.19M38.31M38.64M56.46M57.03M58.63M